BridgeMD
New treatment option for Carotid Artery Stenosis
Official title Balloon Guide Catheter Combined With Filter Protection for Carotid Artery Stenting
ClinicalTrials.gov ID: NCT07247864
What this study is testing
- What it's testing
- This multicenter, randomized, controlled trial evaluates a combined embolic protection strategy during carotid artery stenting (CAS). Carotid artery stenosis is a major cause of stroke.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Occlusion or severe stenosis (70% or greater) of the intracranial segment of the ipsilateral internal carotid artery system;
- Occlusion or severe stenosis (70% or greater) of the contralateral common carotid artery or internal carotid artery;
- History of stenting in the head and neck vessels within 3 months;
- Coexisting other cerebrovascular diseases, such as intracranial aneurysms greater than 5 mm or cerebrovascular malformations;
- Onset of stroke within 7 days;
See the full eligibility criteria
- Occlusion or severe stenosis (70% or greater) of the intracranial segment of the ipsilateral internal carotid artery system;
- Occlusion or severe stenosis (70% or greater) of the contralateral common carotid artery or internal carotid artery;
- History of stenting in the head and neck vessels within 3 months;
- Coexisting other cerebrovascular diseases, such as intracranial aneurysms greater than 5 mm or cerebrovascular malformations;
- Onset of stroke within 7 days;
- Large old infarctions from previous stroke that may confound the evaluation of endpoints;
- Contraindications to magnetic resonance imaging (MRI);
- Definite risk of cardiogenic embolism (e.g., atrial fibrillation, atrial flutter, intracardiac thrombus) or clear indications for anticoagulation therapy;
- Absolute or relative contraindications to antiplatelet therapy;
- Pregnant or lactating women;
- Allergy or hypersensitivity to contrast media or stent materials (e.g., Nitinol);
- Life expectancy less than 1 year;
- Pre-existing neurological or psychiatric disorders (e.g., severe dementia) that would confound neurological assessments;
- Severe renal insufficiency (eGFR less than 30 mL/min).
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Beijing Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Beijing Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.